A/HRC/RES/17/14 Rights, which provide flexibility for that purpose, recognizing that the protection of intellectual property is important for the development of new medicines as well as the concerns about its effects on prices; (h) To foster the development of technology and the voluntary transfer of technology to developing countries on mutually agreed terms aligned with national priorities; (i) To apply measures and procedures for enforcing intellectual property rights in such a manner as to avoid creating barriers to the legitimate trade of affordable, safe, effective and good-quality medicines, and to provide for safeguards against the abuse of such measures and procedures; (j) To strengthen or, where they do not exist, to establish national health regulatory systems that ensure the quality, safety and efficacy of medicines; (k) To promote the improvement of health infrastructures necessary for access to affordable, safe, effective and good-quality medicines, such as storage and distribution systems; 8. Recognizes the innovative funding mechanisms that contribute to the availability of vaccines and medicines in developing countries, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the GAVI Alliance and the International Drug Purchase Facility, UNITAID, and calls upon all States, United Nations programmes and agencies, in particular the World Health Organization, and relevant intergovernmental organizations, within their respective mandates, and encourages relevant stakeholders, including pharmaceutical companies, to further collaborate to enable equitable access to good-quality, safe and efficacious medicines that are affordable to all, including those living in poverty, children and other vulnerable groups; 9. Urges all States, United Nations agencies and programmes and relevant intergovernmental organizations, within their respective mandates, and encourages nongovernmental organizations and relevant stakeholders, to promote the innovative development, the availability and the affordability of new drugs for diseases disproportionately affecting developing countries; 10. Emphasizes the central role of prevention, particularly through the promotion of healthy lifestyles and through the strengthening of health systems, as part of a comprehensive approach to communicable and non-communicable diseases, and urges all States, United Nations agencies and programmes and relevant intergovernmental organizations, within their respective mandates, and encourages non-governmental organizations and relevant stakeholders, including the private sector, to promote innovative research and development, the availability and affordability of safe, effective and goodquality medicines for non-communicable diseases, and to address the challenges arising from the growing burden of such diseases; 11. Requests the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health to prepare, in consultation with States Members of the United Nations, United Nations agencies and programmes, international and non-governmental organizations, and relevant stakeholders, a study on existing challenges with regard to access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, ways to overcome them and good practices, to be presented to the Human Rights Council at its twenty-third session. 4